JUBLINGREAJubilant Ingrevia

₹690.55-0.15%

Market Cap

₹10,981.64 Cr

Stock P/E

38.13

ROCE

11.16%

ROE

8.91%

Book Value

₹190.92

Financials

YoY Net Sales

EPS Growth

Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Foreign Investors

Domestic Investors

Public

From Last Concall

POSITIVES

•
Strong quarterly profitability in Specialty Chemicals, with double-digit YoY growth and stable QoQ.
•
High-margin mix led by Specialty Chemicals and Nutrition, contributing a large share of EBITDA.

NEGATIVES

•
Niacinamide demand remained muted amid customers delaying purchases and competitive offerings.
•
Pricing volatility and external macro risks could impede recovery in some segments.

Peers Summary

Sector Leader

Jubilant Ingrevia Ltd. presents a mixed performance compared to its peers in the Chemicals industry, with moderate growth and profitability metrics, while some peers exhibit superior growth and profitability, indicating a need for strategic focus. Companies like Pidilite Industries and SRF lead in profitability, while others like Godrej Industries are financially risky due to high debt levels.

Key Points

• Jubilant Ingrevia shows stable but low growth; peers like Pidilite and SRF outperform.
• Overvaluation concerns for companies like Godrej Industries and Solar Industries.
• Value picks include Jubilant Ingrevia for its lower debt levels and reasonable valuation.

Top Performers

Pidilite Industries Ltd.

Highest ROE (22.45%) and strong revenue growth (6.12% YoY), showcasing robust profitability.

Solar Industries India Ltd.

High EPS (133.65) and ROE (29.59%), although with recent revenue challenges.

SRF Ltd.

Strong EBITDA margins (23.14%) and revenue growth (11.83% YoY), indicating solid operational performance.

Explore

Watchlists

Command Palette